Volume : 09, Issue : 12, December – 2022
Title:
95.METHOD DEVELOPMENT AND VALIDATION FOR VENLAFAXINE BY RP-HPLC METHOD
Authors :
P.Mounika, S.Saranya
Abstract :
A simple, rapid and accurate stability indicating RP- HPLC method was developed for the quantitative estimation of Venlafaxine in pure and pharmaceutical formulations and the method was validated as per ICH guidelines. In this method Inertsil ODS,C18, 150 mm X 4.6 mm, 5µ column an ambient temperature of 30 0 C and at a flow rate of 0.8 ml. / minute with isocratic elution was used. 20 µ L of the solution was injected and at 267nm wave length the UV detection was made. Phosphate buffer and Acetonitrile in the ratio 30:70 (v/v) was used as mobile Phase and diluent. The retention time for Venlafaxine standard (sample) was found to be 5.011 min and linearity was observed in the concentration range of 12.5 – 75 µ g with correlation coefficient of 1. The %of RSD in precision and accuracy was less than 2. The present method can be successfully used for the routine assay determination of Venlafaxine in pure form and pharmaceutical dosage forms.
Keywords: Venlafaxine, RP‐HPLC, Method development, Validation
Cite This Article:
Please cite this article in press P.Mounika et al, Method Development And Validation For Venlafaxine By RP-HPLC Method.., Indo Am. J. P. Sci, 2022; 09(12).
Number of Downloads : 10
References:
:
1. FDA Approved Drug Products: EFFEXOR XR (venlafaxine extended-release) capsules, for oral use (August 2022)
2. Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, Wong DT: Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology. 2001 Dec;25(6):871-80. (PubMed ID 11750180)
3. Sansone RA, Sansone LA: Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison. Innov Clin Neurosci. 2014 Mar;11(3-4):37-42. (PubMed ID 24800132)
4. Raut BB, Kolte BL, Deo AA, Bagool MA, Shinde DB. A rapid and sensitive high performance liquid chromatographic method for determination of venlafaxine and o-desmethyl venlafaxine in human plasma with UV detection. J LiqChromatogrTechnol 2003;26:1297-313.
5. Juan H, Zhiling Z, Huande L. Simultaneous determination of ßuoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI). J Chromatogra Bio SciAppl 2005;820:33-9.
6. Clement EM, Odontiadis J, Franklin M. Simultaneous measurement of venlafaxine and its major metabolite, O-desmethylvenlafaxine, in human plasma by high-performance liquid chromatography with coulometric detection and utilisation of solid-phase extraction. J Chromatogra Bio SciAppl 1998;705:303-8.
7. Vu RL, Helmeste D, Albers L, Reist C. Rapid determination of venlafaxine and O-desmethylvenlafaxine in human plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogra Bio SciAppl 1997;703:195-201.
8. Li HD, Ding DR, Zhang BK, Yuan HY. Studies on determination of new drug venlafaxine in human plasma by high performance liquid chromatography with fluorimetric detection. YaowuFenxiZazhi 2001;21:240-2.
9. Titier K, Castaing N, Scotto-Gomez E, Molimard M. High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose. Ther Drug Monit 2003;25:581-7.
10. Duverneuil C, de la Grandmaison GL, de Mazancourt P, Alvarez JC. A high-performance liquid chromatography method with photodiode-array UV detection for therapeutic drug monitoring of the nontricyclic antidepressant drugs.Ther Drug Monit 2003;25:567-73.
11. Sarah MR Lambert EE. Development of a solid phase extraction for 13 ‘new’ generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis. J Chromatogra A 2005;1098:19-29.
12. Bhatt J, Jangid A, Venkatesh G, Subbaiah G, Singh S. Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasma. J Chromatogra Bio SciAppl 2005;829:75-81.
13. Frahnert C, Rao ML, Grasmader K. Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: A simple tool for therapeutic drug monitoring. J Chromatogra Bio SciAppl 2003;794:35-47.
14. Asafu-Adjaye EB, Faustino PJ, Tawakkul MA, Anderson LW, Yu LX, Kwon H, et al. Validation and application of a stability-indicating HPLC method for the invitro determination of gastric and intestinal stability of venlafaxine. J Pharm Biomed Anal 2007;43:1854-9.
15. Makhija SN, Vavia PR. Stability indicating LC method for the estimation of venlafaxine in pharmaceutical formulations. J Pharm Biomed Anal 2002;28:1055-9.
16. ICH, Q2A Text on validation of analytical procedures, international conference on harmonization, Oct, 1994.
17. ICH, Q3B validation of analytical procedures: methodology, international conference on harmonization, Nov, 1996.